Hims & Hers Health (HIMS) stock will confirm its short-term direction (either breaking above $50 towards $60-$65 or getting rejected and retesting $40) within the current week.
"Are we going to break above this and run back up to $60 $665 or are we going to get rejected here and come back down to retest 40? I think this week we'll find out."